Skip to main content
. 2019 Jun 27;14(8):1161–1172. doi: 10.2215/CJN.14751218

Figure 2.

Figure 2.

Esaxerenone groups show numerically greater reductions in mean changes in systolic BP and diastolic BP compared with the placebo group at the end of treatment. Data are least square means ±95% confidence interval. *P<0.05 versus placebo; ***P<0.001 versus placebo.